Voltron Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.51M
- Investors
-
3
Voltron Therapeutics General Information
Description
Developer of a vaccine platform designed to treat cancer and infectious diseases. The company develops a proprietary self-assembling vaccine technology that targets peptides for cell-mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, enabling researchers to develop treatments for cancer and infectious diseases.
Contact Information
Website
www.voltrontx.comCorporate Office
- 12 East 49th Street
- 11th Floor
- New York, NY 10017
- United States
Corporate Office
- 12 East 49th Street
- 11th Floor
- New York, NY 10017
- United States
Voltron Therapeutics Timeline
Voltron Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 09-Nov-2023 | $3.51M | Completed | Pre-Clinical Trials | ||
| 3. Grant | 17-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC | 31-Aug-2021 | $5.85M | $9.4M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 09-Jun-2020 | $3.5M | $3.5M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Voltron Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| United States Department of War | Government | |||
| Lucius Partners | Corporation | Minority | ||
| Laidlaw & Company | Investment Bank | Minority |
Voltron Therapeutics Investments (1)
Voltron Therapeutics’s most recent deal was a Joint Venture with HaloVax. The deal was made on 23-Mar-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| HaloVax | 23-Mar-2020 | Joint Venture | Biotechnology |
Voltron Therapeutics FAQs
-
When was Voltron Therapeutics founded?
Voltron Therapeutics was founded in 2017.
-
Where is Voltron Therapeutics headquartered?
Voltron Therapeutics is headquartered in New York, NY.
-
What industry is Voltron Therapeutics in?
Voltron Therapeutics’s primary industry is Drug Discovery.
-
Is Voltron Therapeutics a private or public company?
Voltron Therapeutics is a Private company.
-
What is Voltron Therapeutics’s current revenue?
The current revenue for Voltron Therapeutics is .
-
How much funding has Voltron Therapeutics raised over time?
Voltron Therapeutics has raised $12.9M.
-
Who are Voltron Therapeutics’s investors?
United States Department of War, Lucius Partners, and Laidlaw & Company have invested in Voltron Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process